{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:46:02Z","timestamp":1792651562344,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although optimal therapy for myocardial infarction includes reperfusion to restore blood flow to the ischemic region, ischemia\/reperfusion (IR) also initiates an inflammatory response likely contributing to adverse left ventricular (LV) extracellular matrix (ECM) remodeling. Galectin-3 (Gal-3), a \u03b2-galactoside-binding-lectin, promotes cardiac remodeling and dysfunction. Our aim is to investigate whether Gal-3 pharmacological inhibition using modified citrus pectin (MCP) improves cardiac remodeling and functional changes associated with IR. Wistar rats were treated with MCP from 1 day before until 8 days after IR (coronary artery ligation) injury. Invasive hemodynamics revealed that both LV contractility and LV compliance were impaired in IR rats. LV compliance was improved by MCP treatment 8 days after IR. Cardiac magnetic resonance imaging showed decreased LV perfusion in IR rats, which was improved with MCP. There was no difference in LV hypertrophy in MCP-treated compared to untreated IR rats. However, MCP treatment decreased the ischemic area as well as Gal-3 expression. Gal-3 blockade paralleled lower myocardial inflammation and reduced fibrosis. These novel data showing the benefits of MCP in compliance and ECM remodeling in IR reinforces previously published data showing the therapeutic potential of Gal-3 inhibition.<\/jats:p>","DOI":"10.1038\/s41598-019-46119-6","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T10:03:04Z","timestamp":1562148184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Myocardial Injury After Ischemia\/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition"],"prefix":"10.1038","volume":"9","author":[{"given":"Jaime","family":"Ibarrola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Matilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Gueret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"Fern\u00e1ndez-Celis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Nicol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Jaisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Ouvrard-Pascaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"L\u00f3pez-Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"key":"46119_CR1","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","volume":"67","author":"PC Westman","year":"2016","unstructured":"Westman, P. C. et al. Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction. J. Am. Coll. Cardiol. 67, 2050\u20132060 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"46119_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy, D. J. & Yellon, D. M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 123, 92\u2013100 (2013).","journal-title":"J. Clin. Invest."},{"key":"46119_CR3","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1021\/bi971409c","volume":"37","author":"R-Y Yang","year":"1998","unstructured":"Yang, R.-Y., Hill, P. N., Hsu, D. K. & Liu, F.-T. Role of the Carboxyl-Terminal Lectin Domain in Self-Association of Galectin-3\u2020. Biochemistry 37, 4086\u20134092 (1998).","journal-title":"Biochemistry"},{"key":"46119_CR4","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.carres.2008.08.038","volume":"344","author":"VV Glinsky","year":"2009","unstructured":"Glinsky, V. V. & Raz, A. Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. Carbohydr. Res. 344, 1788\u20131791 (2009).","journal-title":"Carbohydr. Res."},{"key":"46119_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","volume":"33","author":"L Calvier","year":"2013","unstructured":"Calvier, L. et al. Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis. Arterioscler. Thromb. Vasc. Biol. 33, 67\u201375 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"46119_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","volume":"66","author":"E Mart\u00ednez-Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez-Mart\u00ednez, E. et al. Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and HypertensionNovelty and Significance. Hypertension 66, 767\u2013775 (2015).","journal-title":"Hypertension"},{"key":"46119_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1161\/HYPERTENSIONAHA.115.05431","volume":"66","author":"A Tarjus","year":"2015","unstructured":"Tarjus, A. et al. Neutrophil Gelatinase-Associated Lipocalin, a Novel Mineralocorticoid Biotarget, Mediates Vascular Profibrotic Effects of Mineralocorticoids. Hypertens. (Dallas, Tex. 1979) 66, 158\u201366 (2015).","journal-title":"Hypertens. (Dallas, Tex. 1979)"},{"key":"46119_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","volume":"3","author":"L Calvier","year":"2015","unstructured":"Calvier, L. et al. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. JACC. Heart Fail. 3, 59\u201367 (2015).","journal-title":"JACC. Heart Fail."},{"key":"46119_CR9","unstructured":"Perez Garcia, A. (dir) & Smith, J. (dir) Introducci\u00f3n a la sociolog\u00eda. (2005)."},{"key":"46119_CR10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/jcp.22102","volume":"224","author":"J Heger","year":"2010","unstructured":"Heger, J. et al. Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes. J. Cell. Physiol. 224, 120\u20136 (2010).","journal-title":"J. Cell. Physiol."},{"key":"46119_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12305-7","volume":"7","author":"E Mart\u00ednez-Mart\u00ednez","year":"2017","unstructured":"Mart\u00ednez-Mart\u00ednez, E. et al. Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts. Sci. Rep. 7, 12192 (2017).","journal-title":"Sci. Rep."},{"key":"46119_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijcard.2017.12.103","volume":"258","author":"J Ibarrola","year":"2018","unstructured":"Ibarrola, J. et al. A role for fumarate hydratase in mediating oxidative effects of galectin-3 in human cardiac fibroblasts. Int. J. Cardiol. 258, 217\u2013223 (2018).","journal-title":"Int. J. Cardiol."},{"key":"46119_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.amjcard.2010.03.032","volume":"106","author":"AT Turer","year":"2010","unstructured":"Turer, A. T. & Hill, J. A. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am. J. Cardiol. 106, 360\u20138 (2010).","journal-title":"Am. J. Cardiol."},{"key":"46119_CR14","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.ijcard.2014.08.011","volume":"176","author":"GE Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez, G. E. et al. Galectin-3 is essential for early wound healing and ventricular remodeling after myocardial infarction in mice. Int. J. Cardiol. 176, 1423\u20135 (2014).","journal-title":"Int. J. Cardiol."},{"key":"46119_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jchf.2014.07.015","volume":"3","author":"A Lax","year":"2015","unstructured":"Lax, A. et al. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33\/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction. JACC. Heart Fail. 3, 50\u20138 (2015).","journal-title":"JACC. Heart Fail."},{"key":"46119_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2015.06.025","volume":"763","author":"WC Meijers","year":"2015","unstructured":"Meijers, W. C., van der Velde, A. R., Pascual-Figal, D. A. & de Boer, R. A. Galectin-3 and post-myocardial infarction cardiac remodeling. Eur. J. Pharmacol. 763, 115\u201321 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"46119_CR17","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1159\/000494539","volume":"50","author":"S Al-Salam","year":"2018","unstructured":"Al-Salam, S. & Hashmi, S. Myocardial Ischemia Reperfusion Injury: Apoptotic, Inflammatory and Oxidative Stress Role of Galectin-3. Cell. Physiol. Biochem. 50, 1123\u20131139 (2018).","journal-title":"Cell. Physiol. Biochem."},{"key":"46119_CR18","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","volume":"110","author":"UC Sharma","year":"2004","unstructured":"Sharma, U. C. et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 110, 3121\u20138 (2004).","journal-title":"Circulation"},{"key":"46119_CR19","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.ajpath.2015.12.017","volume":"186","author":"O Frunza","year":"2016","unstructured":"Frunza, O. et al. Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis. Am. J. Pathol. 186, 1114\u201327 (2016).","journal-title":"Am. J. Pathol."},{"key":"46119_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1161\/CIRCHEARTFAILURE.112.000146","volume":"6","author":"RAP Weir","year":"2013","unstructured":"Weir, R. A. P. et al. Galectin-3 and cardiac function in survivors of acute myocardial infarction. Circ. Heart Fail. 6, 492\u20138 (2013).","journal-title":"Circ. Heart Fail."},{"key":"46119_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cca.2015.10.034","volume":"452","author":"AR van der Velde","year":"2016","unstructured":"van der Velde, A. R. et al. Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction. Clin. Chim. Acta 452, 50\u201357 (2016).","journal-title":"Clin. Chim. Acta"},{"key":"46119_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ijcard.2016.08.070","volume":"223","author":"RJ Perea","year":"2016","unstructured":"Perea, R. J. et al. Utility of galectin-3 in predicting post-infarct remodeling after acute myocardial infarction based on extracellular volume fraction mapping. Int. J. Cardiol. 223, 458\u2013464 (2016).","journal-title":"Int. J. Cardiol."},{"key":"46119_CR23","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1096\/fj.13-245753","volume":"28","author":"M Besnier","year":"2014","unstructured":"Besnier, M. et al. Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice. FASEB J. 28, 3351\u201361 (2014).","journal-title":"FASEB J."},{"key":"46119_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.carpath.2014.12.001","volume":"24","author":"S Hashmi","year":"2015","unstructured":"Hashmi, S. & Al-Salam, S. Galectin-3 is expressed in the myocardium very early post-myocardial infarction. Cardiovasc. Pathol. 24, 213\u201323 (2015).","journal-title":"Cardiovasc. Pathol."},{"key":"46119_CR25","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1432-2277.2008.00705.x","volume":"21","author":"AP Fernandes Bertocchi","year":"2008","unstructured":"Fernandes Bertocchi, A. P. et al. A Role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury. Transpl. Int. 21, 999\u20131007 (2008).","journal-title":"Transpl. Int."},{"key":"46119_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2009.06.073","volume":"1288","author":"Y-P Yan","year":"2009","unstructured":"Yan, Y.-P., Lang, B. T., Vemuganti, R. & Dempsey, R. J. Galectin-3 mediates post-ischemic tissue remodeling. Brain Res. 1288, 116\u201324 (2009).","journal-title":"Brain Res."},{"key":"46119_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","volume":"6","author":"L Yu","year":"2013","unstructured":"Yu, L. et al. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis. Circ. Heart Fail. 6, 107\u201317 (2013).","journal-title":"Circ. Heart Fail."},{"key":"46119_CR28","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/01.CIR.89.3.1254","volume":"89","author":"V Richard","year":"1994","unstructured":"Richard, V., Kaeffer, N., Tron, C. & Thuillez, C. Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion. Circulation 89, 1254\u20131261 (1994).","journal-title":"Circulation"},{"key":"46119_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1023\/A:1010603217785","volume":"17","author":"C Waller","year":"2001","unstructured":"Waller, C. et al. Myocardial perfusion imaging using a non-contrast agent MR imaging technique. Int. J. Cardiovasc. Imaging 17, 123\u201332 (2001).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"46119_CR30","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/mrm.20373","volume":"53","author":"F Kober","year":"2005","unstructured":"Kober, F., Iltis, I., Cozzone, P. J. & Bernard, M. Myocardial blood flow mapping in mice using high-resolution spin labeling magnetic resonance imaging: influence of ketamine\/xylazine and isoflurane anesthesia. Magn. Reson. Med. 53, 601\u20136 (2005).","journal-title":"Magn. Reson. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46119-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46119-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46119-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T15:35:17Z","timestamp":1721489717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46119-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["46119"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-46119-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,3]]},"assertion":[{"value":"6 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9607"}}